Humacyte, Inc.
HUMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001818382
In the last 90 days, Humacyte, Inc. insiders filed 3 open-market purchases and 0 sales; 164 institutions reported holding it in 13F filings for Q2 2026, worth $57.3M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Humacyte, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 70 | 1 | 78 | +9 |
| Shares | 10.5M | 6.75K | 13.4M | +2.96M (+28.2%) |
| Value | $74.0M | $48.0K | $43.1M | −$30.8M (−41.7%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (22)
Institutions that held Humacyte, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Oconnor LLC | 1,100,000 | $3.53M | 0.04% |
| LPL Financial LLC | 297,540 | $955.0K | 0.00% |
| Marshall Wace, LLP | 58,828 | $189.0K | 0.00% |
| HRT Financial LP | 58,632 | $188.0K | 0.00% |
| New York State Common Retirement Fund | 27,900 | $90.0K | 0.00% |
| Private Advisor Group, LLC | 24,500 | $79.0K | 0.00% |
| Rhumbline Advisers | 21,430 | $69.0K | 0.00% |
| Invesco Ltd. | 19,267 | $63.0K | 0.00% |
| Jump Financial, LLC | 15,100 | $48.0K | 0.00% |
| Powell Investment Advisors, LLC | 14,000 | $45.0K | 0.03% |
| Valley Forge Investment Consultants Inc Adv | 11,000 | $35.0K | 0.02% |
| American International Group, Inc. | 8,260 | $27.0K | 0.00% |
| Deutsche Bank AG | 8,343 | $27.0K | 0.00% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 4,973 | $16.0K | 0.00% |
| UBS Group AG | 5,117 | $16.0K | 0.00% |
| Amalgamated Bank | 4,409 | $14.0K | 0.00% |
| STRS Ohio | 4,100 | $13.0K | 0.00% |
| Ameritas Investment Partners, Inc. | 1,323 | $4.00K | 0.00% |
| Point72 Hong Kong Ltd | 1,395 | $4.00K | 0.00% |
| Addison Advisors LLC | 1,000 | $3.00K | 0.00% |
| FMR LLC | 76 | $0 | 0.00% |
| Urban Wealth Management, LLC | 11 | $0 | 0.00% |
Sold out (13)
Institutions that held Humacyte, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| ExodusPoint Capital Management, LP | 105,525 | $745.0K |
| Squarepoint Ops LLC | 59,531 | $420.0K |
| Weiss Asset Management LP | 49,900 | $352.0K |
| Simplex Trading, LLC | 33,351 | $235.0K |
| Kovack Advisors, Inc. | 31,500 | $222.0K |
| Sciencast Management LP | 26,300 | $182.0K |
| Balyasny Asset Management LLC | 17,272 | $122.0K |
| Y-Intercept (Hong Kong) Ltd | 17,125 | $121.0K |
| Teacher Retirement System of Texas | 10,554 | $75.0K |
| Eudaimonia Partners, LLC | 10,302 | $73.0K |
| Mirabella Financial Services LLP | 10,244 | $72.0K |
| Ovata Capital Management Ltd | 800 | $6.00K |
| Howe & Rusling Inc | 200 | $1.00K |
Not filed for Q2 2022 yet (1)
Institutions that held Humacyte, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Dixon Hughes Goodman Wealth Advisors LLC | 6,750 | $48.0K |